Featured Products

LGM Pharma is proud to present to you our new line of Immunosuppressive Ingredients.

Immunosuppressive drugs inhibit or prevent activity of the immune system.

Currently LGM Pharma supplies the following products, available for your R&D purposes:

Disclaimer: Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

Recent Blog Posts

Immunosuppressive Drugs & Organ Transplantation - Treatments, Side Effects, and Future Research & Development Posted on: 3/17/11 For organ transplant patients, the normally protective immune response can threaten the longevity and function of the transplanted organ. Currently, organ transplant patients must take immunosuppressive or anti-rejection medication to prevent.... More > Monoclonal Antibodies (mAb's) – Growth, Supply, and Uses for Cancer Treatment Posted on: 2/11/11 What is a monoclonal antibody? A monoclonal antibody is a laboratory-produced molecule that's carefully engineered to attach to specific defects in your cancer cells. Monoclonal antibodies mimic the antibodies... More > Dutasteride – FDA Denies Specific Use, But Does Not Affect Existing Approval Posted on: 1/27/11 On Wednesday January 26, 2011, GlaxoSmithKline (GSK) announced that the Company has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for the supplemental New Drug Application (sNDA).... More >